Navigation Links
PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment

A team of researchers at Johns Hopkins Medical Institutions in Baltimore, Md., reports that whole-body positron emission tomography/computed tomography (PET/CT) scans may help physicians identify new, unexpected malignant cancerous tumors in patients, according to an article in the May issue of the Society of Nuclear Medicine's Journal of Nuclear Medicine.

"PET/CT can help find additional lesions in patients known to have cancer," said SNM member Richard L. Wahl, M.D., director of nuclear medicine/PET at the Russell H. Morgan Department of Radiology and Radiological Science. PET/CT scans from nearly 2,000 cancer patients over a two-year period were evaluated retrospectively, explained Wahl, who was one of the first in the world and the first in this country to prove that PET could accurately diagnose breast cancer, melanoma and ovarian cancer and that it was superior to CT in staging lung cancer.

Wahl explained that in patients with known cancer, work-ups focus on a patient's primary disease and incidental coexistence of another primary malignant lesion can be missed. "Such newly identified lesions are often of early stage and have a better likelihood of being cured if treated promptly and aggressively," indicated Wahl, the senior author who co-wrote the JNM article, "Detection of Unexpected Additional Primary Malignancies With PET/CT," with SNM members Takayoshi Ishimori, M.D., Ph.D. (lead author), and Pavni V. Patel, M.D. Results of modern techniques such as PET/CT can be "potentially medically significant and relevant," said Wahl.

PET is a powerful medical imaging modality that noninvasively traces molecular and physiologic processes in the body. Currently, the most common use of PET is for whole-body oncologic imaging for diagnosis, staging, restaging and measuring early therapy responses. CT is an X-ray test that generates a detailed view of the anatomy or structure of organs and tissues in the body. Combining PET with CT provides images showing function (PET) and anatomy (CT) and a merged or "fused" picture of the body's metabolism and structure.


'"/>

Source:Society of Nuclear Medicine


Related biology news :

1. Fox Chase Cancer Center scientists identify immune-system mutation
2. Researchers identify target for cancer drugs
3. Scientists identify genetic pathways essential to RNA interference
4. Scientists identify molecular events that drive cell senescence
5. Scientists identify new model Of NK cell development
6. Chemists identify key gene in development of type 1 diabetes
7. Yale researchers identify molecule for detecting parasitic infection in humans
8. Wisconsin researchers identify sleep gene
9. Chemists identify immune system mechanism for methamphetamine binges
10. Biodiversity hotspots identify conservation priorities
11. Researchers identify protein crucial for survival of Lyme-disease bacterium
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/18/2018)... , ... October 18, 2018 , ... On June 11 ... the emerging field of gene-editing therapeutics to hold its collective breath. Two different ... a high frequency of p53 gene mutation. Mutations in the p53 gene have ...
(Date:10/18/2018)... STATION, Texas (PRWEB) , ... October 18, 2018 ... ... step closer to reality , Texas A&M receives USDA-APHIS deregulation approval , Writer: ... into flour to deliver protein to millions of people, a project to which ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... life sciences, diagnostics, and scientific healthcare companies, proudly announces Insights: Scientific Healthcare ... South San Francisco. In conjunction with co-producer Biocom, the association representing the ...
Breaking Biology News(10 mins):
(Date:10/17/2018)... ... October 17, 2018 , ... PathSensors’ ... have been validated by USDA’s Animal and Plant Health Inspection Service for use ... assays with confidence and trust, knowing they will be able to rapidly and ...
(Date:10/16/2018)... ... October 16, 2018 , ... Infinity Healing Center, along with ... revolutionary technology that effectively treats pain, reduces the need for opioids, and lowers ... technology using photobiomodulation (PBM) has been effective for the treatment of medical conditions ...
(Date:10/16/2018)... ... ... The American Medical Informatics Association (AMIA) is proud to announce the 2018 Signature ... AMIA 2018 Annual Symposium , taking place Nov. 3 – 7, in San Francisco. ... 700 submissions. The AMIA Signature Awards program provides an opportunity for AMIA members at ...
(Date:10/11/2018)... ... October 10, 2018 , ... Boston Biotech Conferences, ... of Wendy Nelson, PhD, as its new CEO. , Dr. Nelson has over ... biotech industry. Most recently, Dr. Nelson was VP of Business Development, Marketing ...
Breaking Biology Technology: